These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2514652)

  • 1. [Effects of cicletanine on plasma lipid metabolism. Mid-term open trial in hypertensive patients with normal blood lipids and hyperlipidemia].
    Rouffy J; Djian F; Aubert I
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():131-4. PubMed ID: 2514652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the optimal dose of the antihypertensive drug cicletanine hydrochloride in man.
    Guinot P; Jewitt-Harris J; Tarrade T
    Arzneimittelforschung; 1989 Jan; 39(1):86-9. PubMed ID: 2655611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term increase in prostaglandin I2 synthesis caused by cicletanine in patients with essential hypertension.
    Yasu T; Imanishi M; Kimura G; Tsuji T; Matsuoka H; Kuramochi M; Omae T
    Am J Hypertens; 1995 Sep; 8(9):944-8. PubMed ID: 8541011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in the glucose tolerance parameters in non-diabetic hypertensive patients treated with cicletanine].
    Clerson P; Carre A; Berthet P; Deltour L; Billaut P; Debeaumont D; Tarrade T; Lefebvre J
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():139-43. PubMed ID: 2514654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cicletanine tolerance in hypertensive patients with metabolic disorders].
    Passa P
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():135-8. PubMed ID: 2514653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dose-effectiveness relationship of cicletanine at short-term in moderately to severely hypertensive patients].
    Fritel D
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():99-102. PubMed ID: 2514676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of three studies to determine the efficacy and tolerance of cicletanine in the short- and long-term treatment of essential hypertension.
    Fodor GP; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):195-204. PubMed ID: 3046883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of diltiazem on lipid profiles and heart rate in hypertensive patients].
    Carré A; Joire JE; Mounier-Vehier C; Lequeuche B
    Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):221-6. PubMed ID: 12555384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the effects of cicletanine on the renin-angiotensin-aldosterone system.
    Bippi H; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):215-20. PubMed ID: 3046885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerance of cicletanine, a new antihypertensive agent: overview of 1226 treated patients.
    Tarrade T; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):205-14. PubMed ID: 3046884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Doxazosin (alpha 1-adrenoreceptor antagonist) used in primary hypertension and it's beneficial effect on lipid metabolism].
    Sznajderman M; Chotkowska E; Peczkowska M; Sawicki M; Janaszek-Sitkowska H; Wiernikowska-Wegorek I; Galewicz A; Cybulska I
    Kardiol Pol; 1993 Feb; 38(2):107-11. PubMed ID: 8230980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reduction of kidney prostaglandin synthesis in patients with essential hypertension. Stimulating effect of cicletanine].
    Hornych A; Boisson J; Gaschard JC
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():85-90. PubMed ID: 2514674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of rhythm tolerance of cicletanine using continuous electrocardiographic recording].
    Witchitz S; Gryner S
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():145-9. PubMed ID: 2514655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cicletanine administered with other antihypertensive agents].
    Grimberg D; Tarrade T; Deschamps de Paillette E
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():109-12. PubMed ID: 2575368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between antihypertensive agents, serum lipids and cigarette smoking in high risk hypertensive patients.
    Plouin PF
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():49-53; discussion 53-4. PubMed ID: 2575176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the effectiveness of a cicletanine-enalapril combination in hypertensive patients].
    Safar M; Cournot P; Duchier J
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():119-24. PubMed ID: 2558622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic effects of an antihypertensive diuretic substance on the forearm circulation of patients with essential hypertension.
    Bouthier JA; Safar ME; Deschamps E; Tarrade T
    Drugs Exp Clin Res; 1988; 14(2-3):221-4. PubMed ID: 3416724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cicletanine and the sympathetic nervous system. A study of awake sino-aortic denervated hypertensive dogs].
    Damase-Michel C; Tran MA; Berthet P; Tarrade T; Montastruc JL
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():55-8. PubMed ID: 2514670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antihypertensive effectiveness and tolerance of cicletanine. Results obtained with bitherapy].
    Tarrade T; Berthet P; Paillasseur JL; Bosquet D; Allard M
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():103-8. PubMed ID: 2575367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.